What this means
This is a summary of ideas about using a harmless virus to deliver genes to the ovaries. It does not show the approach works in people.
Plain-English summary written by an AI model from the abstract. The original is below.
- Who it was tested in
- A review of earlier studies, no new testing reported
- Kind of research
- A summary of earlier studies
The science
- Original title
- AAV9 Gene Therapy for Ovarian Dysfunction and Reproductive Aging: Molecular Mechanisms, Therapeutic Targets, and Translational Perspectives.
- Authors
- Ullah S, Ullah I, Khalil BSF et al.
- Journal
- International journal of molecular sciences
- Published
- Oct 16, 2026
- Study type
- Review · in humans
- PMID
- 42883763 ↗
Abstract
Female infertility is a growing concern in developed countries as delayed childbearing and ovarian dysfunction become more common. Ovarian decline is characterized by follicular depletion, granulosa cell dysfunction, aneuploidy, spindle assembly defects, mitochondrial damage, DNA damage, telomere shortening, stromal remodeling, and cellular senescence. Current approaches (hormonal therapy, assisted reproductive technologies, platelet-rich plasma, stem cells, extracellular vesicles, and mitochondrial-targeted treatments) offer partial benefit but do not directly correct the molecular drivers of ovarian dysfunction. Gene therapy via viral vectors offers a more direct strategy. Adeno-associated virus serotype 9 (AAV9) is attractive for its broad tropism, long-term transgene expression, favorable safety profile, and evidence of ovarian somatic cell transduction, particularly in granulosa and interstitial cells. It remains experimental, however, and requires rigorous evaluation of biodistribution, immune response, off-target effects, germline safety, embryo development, offspring health, and tumorigenic risk. This review summarizes the mechanisms of ovarian dysfunction, current therapeutic limitations, AAV9's advantages, delivery routes, candidate genes, and translational safety concerns.
Ullah S, Ullah I, Khalil BSF et al. AAV9 Gene Therapy for Ovarian Dysfunction and Reproductive Aging: Molecular Mechanisms, Therapeutic Targets, and Translational Perspectives. International journal of molecular sciences. 2026. doi:10.3390/ijms27198516. PMID: 42883763. https://pubmed.ncbi.nlm.nih.gov/42883763/
Related research
Mixing a senescence-clearing drug with trametinib slowed glioma regrowth in mice
Researchers found a drug combination that cleared aging-like tumour cells in mice and slowed regrowth. This does not show the combination would work the same way in children.
Neuronal receptor remodeling in the aging periosteum: From single-cell atlases to regenerative targets.
The periosteum is the most densely innervated compartment of the skeleton and harbors periosteal stem cells expressing a broad repertoire of neuronal receptors traditionally associated with the nervous system.
The Oxidative-Mitochondrial-Inflammatory Axis in Retinitis Pigmentosa: Extracellular mtDNA as Biomarker and Therapeutic Read-Out.
Retinitis pigmentosa (RP) is the most common inherited retinal dystrophy (prevalence ~1:4000) and a leading Mendelian cause of working-age blindness.
Stem cells and exosomes studied for organ aging in animals
This is a review of 34 animal studies on stem cells and exosomes. It suggests these treatments may help aging organs, but the review does not show they work in people.
Fruit fly study finds a gene that helps remove aging gut cells
Researchers found a protein-making gene that rises in aging fruit fly gut cells and helps them get shed. This shows one possible way aging gut cells are cleared, but it is only a fruit fly finding.
Cells from a rare aging syndrome aged faster in a dish
Scientists grew skin-like cells from a patient with a rare aging syndrome and watched them age early. This is a lab study, so it does not show what happens in people.
See all research on PRP for skin and hair (platelet-rich plasma) →